Citadel Advisors - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 29 filers reported holding ACASTI PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q2 2021$62,000
-30.3%
110,889
-59.5%
0.00%
Q4 2020$89,000
-10.1%
273,565
+30.1%
0.00%
Q2 2020$99,000
+266.7%
210,228
+191.2%
0.00%
Q1 2020$27,000
-53.4%
72,188
+204.3%
0.00%
Q4 2019$58,000
+18.4%
23,726
-7.8%
0.00%
Q3 2019$49,000
-2.0%
25,722
-57.3%
0.00%
Q4 2018$50,000
+163.2%
60,218
+84.4%
0.00%
Q2 2018$19,000
-20.8%
32,648
+25.7%
0.00%
Q4 2017$24,000
-44.2%
25,980
-12.9%
0.00%
Q3 2017$43,000
+34.4%
29,843
+23.1%
0.00%
Q2 2017$32,00024,2360.00%
Other shareholders
ACASTI PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Perceptive Advisors 236,559$594,0000.04%
INTACT INVESTMENT MANAGEMENT INC. 89,490$287,0000.01%
BANK OF MONTREAL /CAN/ 210,484$537,0000.00%
DEUTSCHE BANK AG\ 215$00.00%
Tower Research Capital LLC (TRC) 200$1,0000.00%
CITIGROUP INC 30$00.00%
MORGAN STANLEY 18$00.00%
Renaissance Technologies 20,900$53,0000.00%
ROYAL BANK OF CANADA 588$1,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 400$1,0000.00%
View complete list of ACASTI PHARMA INC shareholders